LUNG TRANSPLANTATION - ADULT (LTX) -> LTX - Donor Management and Organ Allocation Abstracts

939 - Donor Lung Utilization for Transplantation in the United States

Presentation Number
939
Speakers
Session Name
POSTER SESSION 2 - POSTER SESSION: Lung Failure/Transplantation - Adult
Date
Thu, Apr 23, 2020
Time
06:00 PM - 07:15 PM
Authors

Previous ePresentation
938 - Improving Lung Procurement and Utilization Rates Using Clinical Practice Guidelines for Ventilation Management

Next ePresentations
940 - Outcome of Marginal Donors in Lung Transplantation, Stretching the Limits
942 - Disparities in the Lung Allocation Score Due to Geography Have Not Changed Since November 2017
947 - Expanding Donor Age Criteria: The UK Experience
949 - Multiple Infrequently Used Types of Marginal Donor Lungs are Not Associated with Inferior Survival among Recipients Aged 65+
951 - The Impact of Elimination of the Donor Service Area (DSA) on United States Lung Transplant Practices and Outcomes at High and Low Competition Centers
954 - Five Year Follow-Up of Staged Bilateral Lung Transplantation for High-Risk Patients with Interstitial Lung Disease: A Matched Case-Control Study
955 - Assessing Lung Transplant Survival Following Donation after Cardiac Death: A Single Center Experience
956 - Use of Donors Who Died by Traumatic Asphyxiation in Lung Transplantation: A Single Center Study
957 - Do Public Health Service Increased Risk Donor Lungs Negatively Affect Survival Outcomes?
959 - Idiopathic Pulmonary Fibrosis Lung Transplant Recipients are at Increased Risk for Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disorder